ClinicalTrials.Veeva

Menu

Whole Body Vibration in Middle Aged Men

J

Jouf University

Status

Not yet enrolling

Conditions

Muscle Weakness
Bone Density

Treatments

Device: Dynatronics VF5 Model vibration platform
Device: Placebo Dynatronics VF5 Model vibration platform

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study aims of this clinical trial is to evaluate the effect of an 8-week Whole Body Vibration (WBV) intervention on Bone Mineral Density (BMD), hand grip strength, and vitamin D levels in middle-aged men. Findings from this study will contribute to understanding whether WBV is a viable alternative to conventional exercise, especially for those with limitations in physical activity.

Study Objectives:

• Primary Objective: To assess the effectiveness of an 8-week WBV intervention in improving BMD, hand grip strength, and vitamin D levels compared to a placebo intervention.

Enrollment

34 estimated patients

Sex

Male

Ages

50+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male participants aged 50 years or older
  • Participants with physical activity or exercise program involvement
  • Participants with no history of serious medical conditions such as tumors, fractures, epilepsy, cardiac disease, or stroke within the past year.
  • Participants must be non-smokers and not receiving hormone or calcium supplement therapy

Exclusion criteria

  • Participants unable to stand on the WBV platform
  • Participants with conditions contraindicating vibration therapy
  • Participants participating in other clinical trials

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

34 participants in 2 patient groups, including a placebo group

Control Group with placebo vibration therapy
Placebo Comparator group
Description:
Participants will perform the same activities as the experimental group, but with a vertical displacement of 0.22 mm, deemed therapeutically insufficient.
Treatment:
Device: Placebo Dynatronics VF5 Model vibration platform
Experimental Group
Experimental group
Description:
Participants will undergo an 8-week WBV therapy program using a Dynatronics VF5 Model vibration platform. Each session will last 4 minutes, with vibration frequencies progressively increased from 25 Hz to 40 Hz without rest intervals.
Treatment:
Device: Dynatronics VF5 Model vibration platform

Trial contacts and locations

1

Loading...

Central trial contact

Fahad Alanazi, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems